Fusion Pharmaceuticals, part of the AstraZeneca Group, is redefining precision oncology with next-generation radioconjugates that deliver powerful alpha-emitting payloads directly to tumors.
Base: 97,132.80 to 127,486.80; Bonus/Equity: Variable Pay Bonus and equity-based long-term incentive eligibility; Benefits: Flex Benefits, Retirement Savings, 4 weeks paid vacation, Personal Days
Must-have
Nice-to-have
Not specified